Melanoma: Radon increases risk for malignant skin cancer according to Swiss researchers
It is undisputed that radon is a risk factor for developing lung cancer. New research by the Swiss Tropical and Public Health Institute (Swiss TPH) in the context of the Swiss National Cohort study now shows that More...
Melanoma drug, Opdivo, gets FDA approval
The U.S. Food and Drug Administration today granted accelerated approval to Opdivo (nivolumab), a new treatment for patients with unresectable (cannot be removed by surgery) or metastatic (advanced) melanoma who More...
Dermatology group release PSA about skin cancer in older men
PRESS RELEASE SCHAUMBURG, Ill. (May 27, 2014) – The American Academy of Dermatology (Academy) today launched “Lawn,” a public service advertisement (PSA) that encourages older men to check their skin for More...
Melanoma/Skin Cancer Detection and Prevention Month: How to Spot Skin Cancer
PRESS RELEASE SCHAUMBURG, Ill. (May 1, 2014) – It is estimated that one in five Americans will be diagnosed with skin cancer in the course of their lifetime, and one person dies from melanoma – the deadliest More...
FDA approves Mekinist in combination with Tafinlar for advanced melanoma
PRESS RELEASE This week the U.S. Food and Drug Administration approved Mekinist (trametinib) in combination with Tafinlar (dabrafenib) to treat patients with advanced melanoma that is unresectable (cannot be removed More...
